|
Alkalaeva, E. Z., Pisarev, A. V., Frolova, L. Y., Kisselev, L. L., Pestova, T. V., 2006. In vitro reconstitution of eukaryotic translation reveals cooperativity between release factors eRF1 and eRF3. Cell 125, 1125-1136.
|
|
Anderson, L. L., Larson, S. A., MapelLentz, S., Hall-Lande, J., 2019. A systematic review of U.S. studies on the prevalence of intellectual or developmental disabilities since 2000. Intellect. Dev. Disabil. 57, 421-438.
|
|
Berridge, M.J., 1998. Neuronal calcium signaling. Neuron 21, 13-26.
|
|
Bezprozvanny, I., 2009. Calcium signaling and neurodegenerative diseases. Trends. Mol. Med. 15, 89-100.
|
|
Hegde, R., Srinivasula, S.M., Datta, P., Madesh, M., Wassell, R., Zhang, Z., Cheong, N., Nejmeh, J., Fernandes-Alnemri, T., Hoshino, S-i., et al., 2003. The polypeptide chain-releasing factor GSPT1/eRF3 is proteolytically processed into an IAP-binding protein. J. Biol. Chem. 278, 38699-38706.
|
|
Hoshino, S-i., Imai, M., Kobayashi, T., Uchida, N., Katada, T., 1999. The eukaryotic polypeptide chain releasing factor (eRF3/GSPT) carrying the translation termination Signal to the 3′-Poly(A) tail of mRNA. J. Biol. Chem. 274, 16677-16680.
|
|
Ishii, T., Ueyama, T., Shigyo, M., Kohta, M., Kondoh, T., Kuboyama, T., Uebi, T., Hamada, T., Gutmann, D.H., Aiba, A., et al., 2017. A novel Rac1-GSPT1 signaling pathway controls astrogliosis following central nervous system injury. J. Biol. Chem. 292, 1240-1250.
|
|
Kurosaki, T., Maquat, L.E., 2016. Nonsense-mediated mRNA decay in humans at a glance. J. Cell Sci. 129, 461-467.
|
|
Leblond, C.S., Le, T-L., Malesys, S., Cliquet, F., Tabet, A-C., Delorme, R., Rolland, T., Bourgeron, T., 2021. Operative list of genes associated with autism and neurodevelopmental disorders based on database review. Mol. Cell. Neurosci. 113, 103623.
|
|
Niemi, M. E. K., Martin, H. C., Rice, D. L., Gallone, G., Gordon, S., Kelemen, M., McAloney, K., McRae, J., Radford, E. J., Yu, S., et al., 2018. Common genetic variants contribute to risk of rare severe neurodevelopmental disorders. Nature 562, 268-271.
|
|
Parenti, I., Rabaneda, L. G., Schoen, H., Novarino, G., 2020. Neurodevelopmental disorders: from genetics to functional pathways. Trends Neurosci. 43, 608-621.
|
|
Ropers, H. H., 2010. Genetics of early onset cognitive impairment. Annu. Rev. Genomics. Hum. Genet. 11, 161-187.
|
|
Sellar, R. S., Sperling, A. S., Slabicki, M., Gasser, J. A., McConkey, M. E., Donovan, K. A., Mageed, N., Adams, D. N., Zou, C., Miller, P. G., et al., 2022. Degradation of GSPT1 causes TP53-independent cell death in leukemia while sparing normal hematopoietic stem cells. J. Clin. Invest. 132, e153514.
|
|
Tarlungeanu, D. C., Novarino, G., 2018. Genomics in neurodevelopmental disorders: an avenue to personalized medicine. Exp. Mol. Med. 50, 1-7.
|
|
Wang, H., Luo, L., Yang, D., 2017. Loss of Gspt1l disturbs the patterning of the brain central arteries in zebrafish. Biochem. Biophys. Res. Commun. 486, 156-162.
|
|
Wright, C. F., McRae, J. F., Clayton, S., Gallone, G., Aitken, S., FitzGerald, T. W., Jones, P., Prigmore, E., Rajan, D., Lord, J., et al., 2018. Making new genetic diagnoses with old data: iterative reanalysis and reporting from genome-wide data in 1,133 families with developmental disorders. Genet. Med. 20, 1216-1223.
|
|
Zaghi, M., Banfi, F., Bellini, E., Sessa, A., 2021. Rare does not mean worthless: how rare diseases have shaped neurodevelopment research in the NGS era. Biomolecules 11, 1713.
|
点击查看大图
下载:
京公网安备 11010502036328号 京ICP备17033152号